Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Hemochromatosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00061763
What this trial is testing

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Who this might be right for
Beta-thalassemiaMyelodysplastic SyndromesFanconi Syndrome+2 more
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Ended earlyNCT03203850
What this trial is testing

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

Who this might be right for
Hereditary Hemochromatosis
Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT00395629
What this trial is testing

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Who this might be right for
Iron OverloadHereditary Hemochromatosis
Novartis Pharmaceuticals 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT00007150
What this trial is testing

Treatment of Hemochromatosis

Who this might be right for
Hemochromatosis
National Institutes of Health Clinical Center (CC) 622
Post-approval studies (Phase 4)Study completedNCT00171301
What this trial is testing

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Who this might be right for
Beta-thalassemia MajorHemosiderosisIron Overload+1 more
Novartis Pharmaceuticals 233
Not applicableStudy completedNCT03654794
What this trial is testing

Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells

Who this might be right for
Hemochromatosis
Rennes University Hospital 26
Not applicableStudy completedNCT00213772
What this trial is testing

Risk Factors of Porphyria Cutanea Tarda (PCT)

Who this might be right for
Porphyria Cutanea Tarda
University Hospital, Strasbourg, France 280
Not applicableStudy completedNCT00005541
What this trial is testing

Hemochromatosis and Iron Overload Screening Study (HEIRS)

Who this might be right for
Blood DiseaseHemochromatosisIron Overload
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Study completedNCT00712738
What this trial is testing

Oral Nifedipine to Treat Iron Overload

Who this might be right for
ThalassemiaIron OverloadHemochromatosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 6
Not applicableStudy completedNCT03066414
What this trial is testing

Respiratory Variations For Assessing Blood Withdrawal

Who this might be right for
Genetic Hemochromatosis
University Hospital, Lille 27
Not applicableStudy completedNCT00001203
What this trial is testing

Deferoxamine for the Treatment of Hemochromatosis

Who this might be right for
Diabetes MellitusHeart DiseaseHemochromatosis+1 more
National Heart, Lung, and Blood Institute (NHLBI) 151
Not applicableStudy completedNCT04631718
What this trial is testing

MRI QSM Imaging for Iron Overload

Who this might be right for
HemochromatosisIron Overload
University of Wisconsin, Madison 63
Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Large-scale testing (Phase 3)UnknownNCT01511848
What this trial is testing

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Who this might be right for
Beta-thalassemia MajorSickle Cell DiseaseIron Hemosiderosis
Ain Shams University 60
Not applicableStudy completedNCT00587535
What this trial is testing

Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration

Who this might be right for
Hemochromatosis
Mayo Clinic 18
Not applicableStudy completedNCT03356548
What this trial is testing

Transferrin Saturation and Asthenia in Hemochromatosis

Who this might be right for
Hemochromatoses, Genetic
Rennes University Hospital 260
Large-scale testing (Phase 3)Ended earlyNCT00122980
What this trial is testing

Stroke With Transfusions Changing to Hydroxyurea

Who this might be right for
HemochromatosisCerebrovascular AccidentAnemia, Sickle Cell+1 more
St. Jude Children's Research Hospital 134
Not applicableLooking for participantsNCT03131427
What this trial is testing

China Registry for Genetic / Metabolic Liver Diseases

Who this might be right for
Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital 20,000
Not applicableWithdrawnNCT01991925
What this trial is testing

Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis

Who this might be right for
Hereditary Haemochromatosis
Universitaire Ziekenhuizen KU Leuven
Testing effectiveness (Phase 2)Looking for participantsNCT07371793
What this trial is testing

Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
Bond Biosciences 34
Next Page